Merida Biosciences clinical trials
Acquired by Eli Lilly and Company, Oct 2026 · source ↗
The registry lists 1 studies whose lead sponsor is Merida Biosciences. 1 is recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 29, 2026.
- 1study on the registry
- 1open to participants now
Before and after it joined Eli Lilly and Company
- First submitted before Merida Biosciences became part of Eli Lilly and Company
- 1
- First submitted after Merida Biosciences became part of Eli Lilly and Company
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Open now1100%
Over the years
- 125
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Merida Biosciences1 study
Something wrong with this grouping? Tell us on the Eli Lilly and Company page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Eli Lilly and Company studies →
- NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' DiseaseRecruitingNCT07305818Phase 1
Sponsor listed in the registry: Merida Biosciences · First submitted before Merida Biosciences became part of Eli Lilly and Company